Related Experiment Video
Updated: Jul 7, 2026

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
Published on: November 2, 2020
Epigenetic inactivation of RASSF2 in oral squamous cell carcinoma
Takashi Imai1, Minoru Toyota, Hiromu Suzuki
1Department of Molecular Biology, Cancer Research Institute, Sapporo Medical University, Sapporo 060-8543, Japan.
Abstract:
Genetic and epigenetic alterations in tumor-suppressor genes play important roles in human neoplasia. Ras signaling is often activated in oral squamous cell carcinoma (OSCC), although Ras mutations are rarely detected in Japanese OSCC patients, and the mechanisms underlying the gene's activation remain unclear. Here, we examined the expression of Ras association family (RASSF) genes in a panel of OSCC cell lines and found that RASSF2 is often downregulated by DNA methylation in OSCC cells. In addition, aberrant methylation of RASSF2 was detected in 12 of 46 (26%) primary OSCC, and 18 (39%) of those OSCC showed methylation of at least one RASSF gene. Ectopic expression of RASSF2 in OSCC cells suppressed cell growth and induced apoptosis. A RASSF2 deletion mutant lacking the Ras-association domain, which was therefore unable to interact with Ras, exhibited less pro-apoptotic activity than the full-length protein, indicating that the pro-apoptotic activity of RASSF2 is related to its association with Ras. Genomic screening of genes regulated by RASSF2 showed that genes involved in immune responses, angiogenesis, and metastasis are suppressed by RASSF2. Our results suggest that epigenetic inactivation of RASSF2 plays an important role in OSCC tumorigenesis, and that RASSF2 may be a useful molecular target for the diagnosis and treatment of OSCC.
Insights
Epigenetic silencing of RASSF2 via DNA methylation is common in oral squamous cell carcinoma (OSCC). Restoring RASSF2 function suppresses tumor growth and may offer a new therapeutic target for OSCC.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Genetic and epigenetic alterations in tumor-suppressor genes are crucial in human neoplasia.
- Ras signaling activation is frequent in oral squamous cell carcinoma (OSCC), but underlying mechanisms are unclear, especially in Japanese populations.
- Ras association family (RASSF) genes are implicated in tumor suppression.
Purpose of the Study:
- To investigate the role of RASSF gene family, particularly RASSF2, in oral squamous cell carcinoma (OSCC) development.
- To determine the mechanisms of RASSF2 dysregulation, focusing on epigenetic modifications like DNA methylation.
- To evaluate the functional impact of RASSF2 on OSCC cell behavior and its potential as a therapeutic target.
Main Methods:
- Analysis of RASSF gene expression in OSCC cell lines.
- Detection of RASSF2 and other RASSF gene methylation in primary OSCC samples.
- Functional studies involving ectopic expression of wild-type and mutant RASSF2 in OSCC cells.
- Genomic screening to identify genes regulated by RASSF2.
Main Results:
- RASSF2 was frequently downregulated by DNA methylation in OSCC cell lines.
- Aberrant methylation of RASSF2 was found in 26% of primary OSCC, and at least one RASSF gene was methylated in 39%.
- Ectopic RASSF2 expression suppressed OSCC cell growth and induced apoptosis, dependent on its Ras-association domain.
- RASSF2 suppressed genes involved in immune response, angiogenesis, and metastasis.
Conclusions:
- Epigenetic inactivation of RASSF2 through DNA methylation is a significant event in OSCC tumorigenesis.
- RASSF2 acts as a tumor suppressor in OSCC, regulating critical cellular processes.
- RASSF2 represents a potential molecular target for OSCC diagnosis and therapy.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
